-
Efalizumab (brand name
Raptiva, Genentech,
Merck Serono) is a
formerly available medication designed to
treat autoimmune diseases,
originally marketed...
-
immunology and
ophthalmology divisions,
managed the
sales of Rituxan,
Raptiva, and Xolair, and
directed Roche's late-stage
portfolio committee for nearly...
- Zorbtive, Luveris, Saizen, Serostim, Glucophage,
Concor and Euthyrox.
Raptiva was
withdrawn in 2007. In the U.S. and Canada,
Merck Serono is
known as...
-
Subcutaneous injection for
moderate to
severe persistent asthma. 2003:
Raptiva (efalizumab):
Antibody designed to
block the
activation and reactivation...
-
Claudio Bertarelli (Chairman)
Ernesto Bertarelli (CEO)
Products Rebif Gonal-f
Luveris Ovidrel/Ovitrelle
Serostim Saizen Zorbtive Raptiva Parent Merck Group...
-
boxed warning was
added on
February 19, 2009, for the drug
efalizumab (
Raptiva)
includes a
statement that
Human polyomavirus 2,
resulting in progressive...
- PROWESS-SHOCK
study Ebrotidine 1998
Spain Hepatotoxicity.
Efalizumab (
Raptiva) 2009
Germany Withdrawn because of
increased risk of
progressive multifocal...
- (dornase alfa), for the
improvement of
pulmonary function in
cystic fibrosis.
Raptiva (efalizumab), for psoriasis,
later withdrawn in 2009 due to the risk of...
- (CF)
Genentech $257 $223 $199 $186.5 $157.1 $143.7 $138.1 $123
efalizumab Raptiva Plaque psoriasis Genentech $108 $107 $90 $79.2 $52.4 $1.4
montelukast Singulair...
-
bacteria Edrecolomab Panorex mab
mouse EpCAM colorectal carcinoma Efalizumab Raptiva mab
humanized LFA-1 (CD11a)
psoriasis (blocks T-cell migration) Efungumab...
